Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-04-25Clinical Trial Update: Melphalan and Panobinostat (LBH589) for the Treatment of Patients With Recurrent Multiple Myeloma [Phase 1, Phase 2]
Results from a Phase 1/2 trial evaluating the combination of melphalan and panobinostat (LBH589) in patients with recurrent multiple myeloma…
-
CLINICAL_TRIALS trial_result · 2014-04-23Clinical Trial Update: Exploratory Study on POL6326 in Stem Cell Mobilization [Phase 2]
An exploratory Phase 2 trial of POL6326 for stem cell mobilization in Multiple Myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Pegylated Liposomal Doxorubicin, Bortezomib, Dexamethasone and Lenalidomide for Relapsed/Refractory Multiple Myeloma [Phase 2]
This Phase 2 trial evaluated a combination therapy of pegylated liposomal doxorubicin, bortezomib, dexamethasone, and lenalidomide in relaps…
-
CLINICAL_TRIALS trial_result · 2014-04-17Clinical Trial Update: PAV-trial: Plerixafor and Chemotherapy With Vinorelbine for Stem Cell Mobilization in Patients With Myeloma [Phase 2]
Phase 2 study evaluating Plerixafor in combination with vinorelbine for stem cell mobilization in patients with multiple myeloma has complet…
-
CLINICAL_TRIALS trial_result · 2014-04-17Clinical Trial Update: Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer [Phase 3]
Phase 3 trial update evaluating laboratory-treated donor bone marrow in patients undergoing donor stem cell transplant for hematologic cance…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-04-15Clinical Trial Update: Melphalan and Palifermin in Treating Patients Undergoing An Autologous Peripheral Stem Cell Transplant for Stage II or III Multiple Myeloma [Phase 1]
A Phase 1 study evaluated safety and feasibility of combining melphalan with palifermin in patients undergoing autologous peripheral stem ce…
-
CLINICAL_TRIALS trial_result · 2014-04-10Clinical Trial Update: Celgene High Risk Multiple Myeloma (MM) Revlimid Induction and Maintenance Therapy [Phase 2]
A Phase 2 trial evaluating lenalidomide (Revlimid) as induction and maintenance therapy for high-risk multiple myeloma has completed, with r…
-
CLINICAL_TRIALS trial_result · 2014-04-09Clinical Trial Update: Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma. [Phase 3]
A Phase 3 clinical trial comparing denosumab with zoledronic acid for treating bone metastases in advanced cancer or multiple myeloma has co…
-
CLINICAL_TRIALS trial_result · 2014-04-04Clinical Trial Update: Safety Study of Lenalidomide Maintenance Therapy Post Allogeneic HCT for High-risk Multiple Myeloma [Phase 2]
A Phase 2 safety study evaluating lenalidomide maintenance after allogeneic hematopoietic cell transplantation in high-risk multiple myeloma…
-
CLINICAL_TRIALS trial_result · 2014-04-04Clinical Trial Update: Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma [Phase 3]
Phase 3 trial evaluating dexamethasone with or without thalidomide in newly diagnosed multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2014-04-02Clinical Trial Update: Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma [Phase 2]
Phase 2 clinical trial evaluating busulfan and cyclophosphamide with autologous stem cell transplant in multiple myeloma has completed with …
-
CLINICAL_TRIALS research · 2014-03-26Clinical Trial Update: Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination [Phase 1, Phase 2]
Open-label Phase 1/2 clinical trial evaluating the safety and tolerability of donor-derived allogeneic B-cell concentrates to support immune…
-
CLINICAL_TRIALS trial_result · 2014-03-24Clinical Trial Update: Oligosecretary Myeloma: Prevalence and Its Clinical Significance
A completed study from Samsung Medical Center investigates the prevalence of oligosecretory myeloma and its clinical significance.
-
CLINICAL_TRIALS trial_result · 2014-03-21Clinical Trial Update: Vaccine Therapy With or Without Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Multiple Myeloma Undergoing Donor Stem Cell Transplant [Phase 1]
Phase 1 trial evaluating vaccine therapy with or without donor lymphocyte infusion in patients with acute myeloid leukemia, acute lymphoblas…
-
CLINICAL_TRIALS trial_result · 2014-03-21Clinical Trial Update: Velcade (Bortezomib), Adriamycin Dexamethasone (PAD) or Vincristine Adriamycin Dexamethasone in Second Line Treatment of Multiple Myeloma [Phase 2]
A Phase 2 study evaluating second-line regimens PAD (bortezomib, doxorubicin, dexamethasone) or vincristine-doxorubicin-dexamethasone in mul…
-
FDA approval · 2014-03-13FDA Approved: POMALYST — Supplemental Application (Celgene Corporation)
The FDA approved a supplemental application for POMALYST (pomalidomide) submitted by Celgene Corporation. This represents an update to the p…
-
CLINICAL_TRIALS trial_result · 2014-03-07Clinical Trial Update: Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
A Phase 2 clinical trial evaluating chemotherapy plus biological therapy followed by peripheral stem cell transplantation for hematologic ca…
-
CLINICAL_TRIALS trial_result · 2014-03-07Clinical Trial Update: Thalidomide to Patients With Previously Untreated Multiple Myeloma [Phase 3]
Phase 3 clinical trial update on thalidomide in patients with previously untreated multiple myeloma; the study status is reported as complet…
-
CLINICAL_TRIALS research · 2014-03-05Clinical Trial Update: Level of Physical Activity and Its Associations With Fatigue and Quality of Life in Multiple Myeloma Survivors
Clinical trial update examining how levels of physical activity relate to fatigue and quality of life in multiple myeloma survivors. The sta…
-
CLINICAL_TRIALS trial_result · 2014-03-04Clinical Trial Update: Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD) [Phase 3]
Phase III randomized trial in multiple myeloma comparing thalidomide/dexamethasone vs vincristine/adriamycin/dexamethasone was terminated wi…
-
CLINICAL_TRIALS trial_result · 2014-03-03Clinical Trial Update: A Study of Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Untreated Multiple Myeloma and Planned for a High Dose Chemotherapy [Phase 2]
Phase 2 trial evaluating the combination of bortezomib, cyclophosphamide, and dexamethasone in untreated multiple myeloma patients planned f…
-
CLINICAL_TRIALS trial_result · 2014-02-28Clinical Trial Update: Study on the Safety, Anti-tumor Activity and Pharmacology of IPH2101 Combined With Lenalidomide in Patients With Multiple Myeloma Experiencing a First or Second Relapse [Phase 1]
Phase 1 study evaluating the safety, anti-tumor activity, and pharmacology of IPH2101 in combination with lenalidomide in patients with mult…
-
CLINICAL_TRIALS trial_result · 2014-02-25Clinical Trial Update: Agaricus Blazei Murill in Patients With Multiple Myeloma [Phase 2]
A phase 2 clinical trial evaluating Agaricus blazei Murill extract in patients with multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2014-02-11Clinical Trial Update: Evaluation of the Safety and Efficacy of the Addition of AMD3100 to a G-CSF Mobilization Regimen in Patients With Lymphoma (NHL and HD) and Multiple Myeloma (MM). [Phase 2]
A Phase 2 trial evaluated the safety and efficacy of adding AMD3100 to a G-CSF mobilization regimen in patients with non-Hodgkin lymphoma, H…
-
CLINICAL_TRIALS trial_result · 2014-02-11Clinical Trial Update: Open Label Extension to SRE Studies in United Kingdom and Czech Republic Only [Phase 3]
Phase 3 open-label extension updates for skeletal-related events in patients with bone metastases from prostate cancer and breast cancer (an…